Cancer Targeted Technology LLC
Last verified 2026-05-02. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $2.0Mattributed |
|---|---|
| Latest round | grant, $2.0M, 2025-01-01attributed |
| Founded | unknown |
| Headquarters | Pullman, Washington |
| Industry | bio |
| Stage | unknown |
| Website | cancertargetedtechnology.com |
Cancer Targeted Technology develops small-molecule drugs that pair diagnostic imaging agents with paired therapies, with prostate cancer as the lead indication. It serves oncology programs and partners building theranostic pipelines. The integrated diagnostic-plus-therapeutic approach lets the same molecule guide and treat the disease.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-01-01 | grant | $2.0M | undisclosed |
Detected tech stack
Apache HTTP Server, Google Analytics, Google Tag Manager, Prototype, DoubleClick Floodlight, WordPress, PHP, MySQL, apache
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $2.0M | attributed | sbir named as publisher. No document URL on file. |
| Total raised $2.0M | attributed | sbir named as publisher. No document URL on file. |
| Company existence | self-reported | cancertargetedtechnology.com, read 2026-05-02 |
| Description | self-reported | cancertargetedtechnology.com, read 2026-05-02 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.